1st day (Feb. 16th, Saturday)
Official Language: English |
| Registration |
08:30-08:50 |
| Opening remarks |
08:50-09:00 |
| I. Risk Factors (Chairmen: Jung Gu Kim and Robert Wen-Wei Hsu) |
09:00-10:40 |
1. Epidemiology and socio-economic burden of osteoporosis and fracture.
Nam H. Cho (Korea) |
09:00-09:30 |
2. Genetics and SNP analysis of osteoporosis.
Dong Ock Lee (Korea) |
09:30-09:50 |
3. Nutrition and prevention of osteoporosis.
Takako Hirota (Japan) |
09:50-10:20 |
| 4. Discussion. |
10:20-10:40 |
| Coffee Break |
10:40-11:00 |
| II. Pathophysiology (Chairperson: Ghi Su Kim ) |
11:00-12:00 |
| 1. Primary osteoporosis. Yoo Mee Kim (Korea) |
11:00-11:20 |
| 2. Secondary osteoporosis. Chan Soo Shin (Korea) |
11:20-11:40 |
| 3. Discussion |
11:40-12:00 |
| Plenary Lecture: Chairman: Woong Hwan Choi |
|
| Osteoclastogenesis and vitamin D. Tatsuo Suda (Japan) |
12:00-12:40 |
| Luncheon |
12:40-13:40 |
| III. Bone Biology (Chairmen: Toshiyuki Yoneda , Hyun-Mo Ryoo) |
13:40-15:00 |
1. Regulation of osteoblast differentiation by BMP
and Notch signaling. Akira Yamaguchi (Japan) |
13:40-14:10 |
| 2. Role of chondrocyte in bone. Ung-il Chung (Japan) |
14:10-14:40 |
| 3. Discussion |
14:40-15:00 |
| Coffee Break |
15:00-15:20 |
IV. Diagnostic Methods
(Chairmen: Seoung-Oh Yang accepted, Deog Yoon Kim ) |
15:20-18:00 |
| 1. The future of DXA – more than just BMD. Kevin Wilson (USA) |
15:20-15:50 |
| 2. QCT and biomechanics. Keenan (USA) |
15:50-16:20 |
| 3. Biochemical bone markers. Yoon-Sok Chung (Korea) |
16:20-16:40 |
| 4. Histomorphometric analysis. Satoshi Mori (Japan) |
16:40-17:10 |
| 5. Role of chondrocyte in bone. Ung-il Chung (Japan) |
17:10-17:40 |
| 6. Discussion |
17:40-18:00 |
| Dinner |
18:00-20:00 |
2nd day (Feb. 17th, Sunday)
Official Language: Korean (English for overseas speakers) |
| Registration |
08:00-08:30 |
Plenary Lecture: Chairman: Sung-Kil Lim |
|
| Role of vitamin D in osteoporosis treatment. Hajime Orimo (Japan) |
08:30-09:10 |
| V. Treatments, new trends and perspectives |
09:10-13:00 |
| A) Estrogen & SERM (Chairman: Hoon Choi ) |
09:10-10:00 |
| 1. Clinical & low dose estrogen. Hong-Yuan Huang (Taiwan) |
09:10-09:30 |
| 2. Selective Estrogen Receptor Modulator. Byung Koo Yoon (Korea) |
09:30-09:50 |
| 3. Discussion |
09:50-10:00 |
| B) Bisphosphonates (Chairman: Ye Yeon Won ) |
10:00-11:00 |
| 1. Daily or weekly bisphosphonates. Takayuki Hosoi (Japan) |
10:00-10:25 |
| 2. Monthly or yearly bisphosphonates. Dong Won Byun (Korea) |
10:25-10:50 |
| 3. Discussion |
10:50-11:00 |
| Coffee Break |
11:00-11:20 |
| C) Anabolic agents (Chairman: Moo Il Kang ) |
11:20-12:10 |
| 1. Parathyroid hormone. Yumie Rhee |
11:20-11:40 |
| 2. Strontium ranelate. Ho-Yeon Chung (Korea) |
11:40-12:00 |
| 3. Discussion |
12:00-12:10 |
| D) Surgery for osteoporotic fractures (Chairman: JM Lee ) |
12:10-13:00 |
| 1. Spine fractures. Hak Sun Kim (Korea) |
12:10-12:30 |
| 2. Hip fractures. Robert Wen-Wei Hsu (Taiwan) |
12:30-12:50 |
| 3. Discussion |
12:50-13:00 |
| Luncheon |
13:00-14:00 |
| Closing remarks |
14:00-14:20 |